# Phase 11 — Action 11.15 Residual Risk and Final Completion Gate

## Objective

Perform an independent closure review before declaring Phase 11 complete.

This action introduces no new security or product behavior.

It verifies:

- completion of Actions 11.1 through 11.14;
- disposition of every confirmed finding/hardening;
- regression evidence;
- bounded synthetic runtime;
- residual-risk disclosure;
- evidence integrity;
- claim limitations;
- Git integrity.

## Parent checkpoint

Branch:

`security/phase-11-agent-action-mcp-tool-code-execution-security`

Parent HEAD:

`3f06336b02c5de8e50d0822e319eace134089014`

## Findings disposition

### H11-01

Generic tool-result instruction/data trust boundary.

**REMEDIATED**

### H11-02

Custom OpenAPI action outbound SSRF control.

**MITIGATED WITH DOCUMENTED RESIDUAL**

Residual:

DNS validation-to-connect race remains on the generic custom-action requests
transport.

### H11-03

Raw generic tool argument/output tracing.

**REMEDIATED**

### H11-04

Unbounded per-cycle valid-tool fan-out.

**REMEDIATED**

## Findings summary

Confirmed findings/hardenings:

**4**

Fully remediated:

**3**

Mitigated with explicit residual risk:

**1**

Confirmed findings without a disposition:

**0**

Phase 11 therefore does not claim that all residual risk is eliminated.

## Independent final runtime smoke

The integrated synthetic agent-runtime regression was rerun from the final
engineering checkpoint using:

- the pinned backend image;
- actual repository code;
- synthetic identities/data;
- Docker network disabled.

Verified properties included:

- bounded tool fan-out;
- tool-result trust boundary;
- MCP header authority;
- managed credential precedence;
- strictest approval policy;
- unsafe metadata destination blocking;
- trace-content minimization.

**PASS**

## Evidence integrity

Action 11.13 runtime results SHA-256:

`ea3449968c8ba3e907bf4460d17b1084b9ce5302697a220877f65bff1c0cb0de`

Action 11.14 regression results SHA-256:

`17fee7cd9e41ab0b959e6ad9b547dadc0af6e7b8d4162f51f0d811844702bb71`

Action 11.15 final-gate results SHA-256:

`52eb9c228fc775fde70476388057808414c27a68d59232895b31bd91c92a5fb2`

## Explicit residual risks

The final Phase 11 record retains:

1. DNS validation-to-connect race for generic custom-action HTTP transport;
2. tool-specific exception and stack-trace content;
3. third-party MCP/provider behavior;
4. production OAuth/provider revocation behavior;
5. unknown kernel/container vulnerabilities;
6. sophisticated real-model indirect prompt-injection behavior;
7. production-scale latency and economic behavior;
8. deployment/operator configuration and incident-response risk.

## Claims deliberately not made

Phase 11 does not claim:

- exploitation of public Onyx deployments;
- exploitation of real MCP services;
- arbitrary-model immunity to prompt injection;
- full production OAuth/provider behavior;
- production container-escape assurance;
- production-scale agent-runtime assurance;
- elimination of all SSRF risk;
- formal NIST/OWASP/MITRE certification.

## Evidence-strength conclusion

Phase 11 contains:

- source and architecture tracing;
- deterministic unit/property tests;
- synthetic authorization testing;
- MCP header and credential testing;
- approval/confused-deputy analysis;
- indirect tool-result injection hardening;
- delegated credential analysis;
- SSRF testing and mitigation;
- sandbox/code-execution containment review;
- secret/telemetry remediation;
- agent resource-bound remediation;
- consolidated attack matrix;
- integrated bounded repository-code runtime;
- regression evidence;
- framework-oriented engineering mapping;
- explicit residual-risk documentation.

This constitutes a completed authorized local AI Application & Product
Security engineering assessment for the defined Phase 11 scope.

## Final gate

- Actions complete: **15/15**
- Findings/hardenings: **4**
- Fully remediated: **3**
- Mitigated with documented residual: **1**
- Unaddressed confirmed findings: **0**
- Regression gate: **PASS**
- Bounded agent runtime: **PASS**
- Evidence integrity: **PASS**
- Residual risk disclosure: **PASS**
- Production-runtime overclaim: **NO**
- Compliance/certification overclaim: **NO**

## Completion

**ACTION 11.15: COMPLETE**

**PHASE 11: COMPLETE — 15/15 ACTIONS**

**RESULT=PHASE_11_ACTION_11_15_PASS**
